AVRDB — Anteris Technologies Income Statement
0.000.00%
HealthcareSmall Cap
- AU$214.14m
- AU$205.29m
- AU$7.03m
Annual income statement for Anteris Technologies, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.2 | 9.57 | 9.27 | 6.73 | 7.03 |
Cost of Revenue | |||||
Gross Profit | 8.38 | 6.84 | 7.63 | 4.74 | 5.43 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 23.3 | 24.8 | 30.8 | 52 | 74.7 |
Operating Profit | -6.18 | -15.3 | -21.5 | -45.2 | -67.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.18 | -15.3 | -22.9 | -44.3 | -69.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.18 | -15.3 | -22.9 | -44.3 | -68.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.82 | -15.3 | -22.9 | -44.3 | -67.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.82 | -15.3 | -22.9 | -44.3 | -67.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.56 | -2.58 | -3.09 | -3.32 | -4.31 |